{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:58:34Z","timestamp":1781233114321,"version":"3.54.1"},"reference-count":53,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health from PNRR plan","award":["PNRR-2022-BIOPSY_GIANT_CELL"],"award-info":[{"award-number":["PNRR-2022-BIOPSY_GIANT_CELL"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Heart transplantation (HTx) is a lifesaving procedure for end-stage heart failure patients; however, postoperative infections remain a major challenge due to immunosuppressive therapy and surgical complications. Traditional biomarkers such as C-reactive protein (CRP) and procalcitonin (PCT) have limitations in distinguishing infections from systemic inflammatory response syndrome (SIRS). Emerging markers such as Presepsin and interleukin-6 (IL-6) may improve diagnostic accuracy. This study aimed to evaluate the kinetics and reliability of these four inflammatory biomarkers in heart transplant recipients in the immediate postoperative period. Methods: This retrospective observational study included 126 patients who underwent HTx at Policlinic of Bari between January 2022 and November 2024. Patients were categorized into infected (n = 26) and non-infected (n = 100) groups based on clinical and microbiological criteria. Biomarkers (CRP, PCT, Presepsin, and IL-6) were measured preoperatively and on postoperative days (PODs) 1, 2, 3, 4, 5, and 10. Statistical analyses included the Mann\u2013Whitney U test and logistic regression to identify the independent predictors of infection. Results: CRP and PCT levels differed significantly between the groups only on day 10, limiting their use as early infection markers. In contrast, Presepsin levels were significantly elevated in infected patients from day 1 (p &lt; 0.001), whereas IL-6 levels showed significant differences from day 3 onward. Presepsin showed the strongest association with infection in the early postoperative phase. Conclusions: Presepsin and IL-6 outperformed CRP and PCT in detecting early postoperative infections in heart transplant recipients. Their early elevation supports their use as reliable markers for guiding timely clinical intervention and improving patient outcomes. Further research is needed to validate these findings in larger cohorts and with different immunosuppressive regimens.<\/jats:p>","DOI":"10.3390\/jcm14155369","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T16:16:10Z","timestamp":1753805770000},"page":"5369","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Kinetics of Procalcitonin, CRP, IL-6, and Presepsin in Heart Transplant Patients Undergoing Induction with Thymoglobulin (rATG)"],"prefix":"10.3390","volume":"14","author":[{"given":"Lorenzo","family":"Giovannico","sequence":"first","affiliation":[{"name":"Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Medical School, Piazza Giulio Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8746-729X","authenticated-orcid":false,"given":"Vincenzo Ezio","family":"Santobuono","sequence":"additional","affiliation":[{"name":"University Cardiology Unit, Interdisciplinary Department of Medicine, University of Bari Aldo Moro, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8804-8013","authenticated-orcid":false,"given":"Giuseppe","family":"Fischetti","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Medical School, Piazza Giulio Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Mazzone","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Medical School, Piazza Giulio Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Parigino","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Medical School, Piazza Giulio Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Savino","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Medical School, Piazza Giulio Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Alfeo","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Medical School, Piazza Giulio Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Domenico","family":"Milano","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Medical School, Piazza Giulio Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Igoren","family":"Guaricci","sequence":"additional","affiliation":[{"name":"University Cardiology Unit, Interdisciplinary Department of Medicine, University of Bari Aldo Moro, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Matteo","family":"Ciccone","sequence":"additional","affiliation":[{"name":"University Cardiology Unit, Interdisciplinary Department of Medicine, University of Bari Aldo Moro, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7535-9670","authenticated-orcid":false,"given":"Massimo","family":"Padalino","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Medical School, Piazza Giulio Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomaso","family":"Bottio","sequence":"additional","affiliation":[{"name":"Cardiac Surgery Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Medical School, Piazza Giulio Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.healun.2024.05.010","article-title":"International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024","volume":"43","author":"Peled","year":"2024","journal-title":"J. Heart Lung Transplant."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J. Heart Lung Transplant."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s10741-021-10178-7","article-title":"Evaluation of donor heart for transplantation","volume":"27","author":"Tatum","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11886-021-01631-y","article-title":"Heart Transplant Donor Selection Guidelines: Review and Recommendations","volume":"24","author":"Sathianathan","year":"2022","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12981","DOI":"10.3389\/ti.2024.12981","article-title":"Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support in New Era of Heart Transplant","volume":"37","author":"Giovannico","year":"2024","journal-title":"Transpl. Int."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bifulco, O., Bottio, T., Caraffa, R., Carrozzini, M., Guariento, A., Bejko, J., Fedrigo, M., Castellani, C., Toscano, G., and Lorenzoni, G. (2022). Marginal versus Standard Donors in Heart Transplantation: Proper Selection Means Heart Transplant Benefit. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092665"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.rcl.2023.04.011","article-title":"Heart Transplantation: Indications, Surgical Techniques, and Complications","volume":"61","author":"Wu","year":"2023","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/sur.2019.073","article-title":"In-Hospital Post-Operative Infection after Heart Transplantation: Epidemiology, Clinical Management, and Outcome","volume":"21","year":"2020","journal-title":"Surg. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.healun.2023.07.011","article-title":"Management and outcomes of heart transplant candidates with bloodstream infection on temporary mechanical circulatory support","volume":"42","author":"Eichenberger","year":"2023","journal-title":"J. Heart Lung Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.transproceed.2006.08.087","article-title":"Infections in cardiac transplant recipients: Clinical and microbiological characteristics and consequences","volume":"38","author":"Lage","year":"2006","journal-title":"Transplant. Proc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccc.2018.08.010","article-title":"Infections in Heart and Lung Transplant Recipients","volume":"35","author":"Alsaeed","year":"2019","journal-title":"Crit. Care Clin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"4","author":"Fishman","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.transproceed.2016.11.034","article-title":"Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review","volume":"49","author":"Ruan","year":"2017","journal-title":"Transplant. Proc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.healun.2015.04.001","article-title":"Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab","volume":"34","author":"Ansari","year":"2015","journal-title":"J. Heart Lung Transpl."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/tri.12480","article-title":"Thymoglobulin induction in heart transplantation: Patient selection and implications for maintenance immunosuppression","volume":"28","author":"Zuckermann","year":"2015","journal-title":"Transpl. Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2174\/1381612826666200603130232","article-title":"A Comprehensive and Contemporary Review on Immunosuppression Therapy for Heart Transplantation","volume":"26","author":"Goldraich","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/164_2021_552","article-title":"Immunosuppression and Heart Transplantation","volume":"272","author":"Sutaria","year":"2022","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ccc.2023.05.004","article-title":"Heart Transplantation-Postoperative Considerations","volume":"40","author":"Demiralp","year":"2024","journal-title":"Crit. Care Clin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.healun.2007.05.002","article-title":"Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy","volume":"26","author":"Mattei","year":"2007","journal-title":"J. Heart Lung Transpl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1016\/j.transproceed.2014.08.042","article-title":"Anti-thymocyte gamma-globulin may prevent antibody production after heart transplantation","volume":"46","author":"Rafiei","year":"2014","journal-title":"Transpl. Proc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/tri.12107","article-title":"Induction therapy in heart transplantation: Where are we now?","volume":"26","author":"Aliabadi","year":"2013","journal-title":"Transpl. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.trim.2008.11.004","article-title":"Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury","volume":"20","author":"Chappell","year":"2009","journal-title":"Transpl. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/anr3.12092","article-title":"Severe anti-thymocyte globulin-induced cytokine release syndrome in a renal transplant patient","volume":"9","author":"Huh","year":"2021","journal-title":"Anaesth. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMoa1415236","article-title":"Systemic inflammatory response syndrome criteria in defining severe sepsis","volume":"372","author":"Kaukonen","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Binnie, A., Lage, J., and Dos Santos, C.C. (2020). How can biomarkers be used to differentiate between infection and non-infectious causes of inflammation?. Evidence-Based Practice of Critical Care, Elsevier.","DOI":"10.1016\/B978-0-323-64068-8.00055-9"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"RRyu, J.-A., Yang, J.H., Lee, D., Park, C.-M., Suh, G.Y., Jeon, K., Cho, J., Baek, S.Y., Carriere, K.C., and Chung, C.R. (2015). Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138150"},{"key":"ref_27","first-page":"e1","article-title":"Cytokine Release Syndrome during Antithymocyte Globulin\/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading Criteria","volume":"28","author":"Knaus","year":"2022","journal-title":"Transplant. Cell Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.biopha.2018.12.124","article-title":"Presepsin: A promising biomarker for the detection of bacterial infections","volume":"111","author":"Memar","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10156-005-0400-4","article-title":"Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis","volume":"11","author":"Yaegashi","year":"2005","journal-title":"J. Infect. Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13054-015-1032-4","article-title":"The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: A meta-analysis","volume":"19","author":"Zhang","year":"2015","journal-title":"Crit. Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1002\/jcb.27870","article-title":"The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: A systematic review and meta-analysis","volume":"120","author":"Tan","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yoon, S.H., Kim, E.H., Kim, H.Y., and Ahn, J.G. (2019). Presepsin as a diagnostic marker of sepsis in children and adolescents: A systemic review and metaanalysis. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4397-1"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00134-014-3514-2","article-title":"Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: Data from the multicenter, randomized ALBIOS trial","volume":"41","author":"Masson","year":"2015","journal-title":"Intensive Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5005\/jp-journals-10071-23715","article-title":"Role of presepsin for diagnosis of sepsis and ICU mortality. A prospective controlled study","volume":"25","author":"Abdelshafey","year":"2021","journal-title":"Indian. J. Crit. Care Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","article-title":"Biomarkers of sepsis: Time for a reappraisal","volume":"24","author":"Pierrakos","year":"2020","journal-title":"Crit. Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1309\/AJCP1MFYINQLECV2","article-title":"Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department","volume":"135","author":"Riedel","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1100\/tsw.2010.181","article-title":"Diagnostic and prognostic role of procalcitonin in infections","volume":"10","author":"Hatzistilianou","year":"2010","journal-title":"Sci. World J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5114\/ait.2019.88104","article-title":"Sepsis diagnosis and monitoring-procalcitonin as standard, but what next?","volume":"51","year":"2019","journal-title":"Anaesthesiol. Intensive. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hirano, T., Narazaki, M., and Kishimoto, T. (2014). IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol., 6.","DOI":"10.1101\/cshperspect.a016295"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/intimm\/dxq030","article-title":"IL-6: From its discovery to clinical applications","volume":"22","author":"Kishimoto","year":"2010","journal-title":"Int. Immunol."},{"key":"ref_41","first-page":"41","article-title":"IL-6 pathway and its inhibitors in heart failure","volume":"202","author":"Ruan","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_42","first-page":"123","article-title":"The role of IL-6 in the pathophysiology of inflammatory and autoimmune diseases","volume":"205","author":"Kumar","year":"2020","journal-title":"J. Immunol."},{"key":"ref_43","first-page":"2327","article-title":"Activation of interleukin-6 gene expression through the NF-kappa B transcription factor","volume":"10","author":"Libermann","year":"1990","journal-title":"Mol. Cell Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/cc6202","article-title":"Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin","volume":"11","author":"Zazula","year":"2007","journal-title":"Crit. Care"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/cc7749","article-title":"Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: A prospective study","volume":"13","author":"Brodska","year":"2009","journal-title":"Crit. Care"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s001340100949","article-title":"Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies","volume":"27","author":"Sabat","year":"2001","journal-title":"Intensive. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: All we need to know about danger","volume":"81","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60532-5","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira","year":"1993","journal-title":"Adv. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-065X.1992.tb01407.x","article-title":"IL-6 and NF-IL6 in acute-phase response and viral infection","volume":"127","author":"Akira","year":"1992","journal-title":"Immunol. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1411569","article-title":"Interleukin-6 and its receptor: A paradigm for cytokines","volume":"258","author":"Kishimoto","year":"1992","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood.V74.4.1360.1360","article-title":"Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman\u2019s disease","volume":"74","author":"Yoshizaki","year":"1989","journal-title":"Blood"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5369\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:18:28Z","timestamp":1760033908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":53,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14155369"],"URL":"https:\/\/doi.org\/10.3390\/jcm14155369","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]}}}